143 related articles for article (PubMed ID: 8174849)
1. High levels of erythrocyte aldose reductase and diabetic retinopathy in NIDDM patients.
Nishimura C; Saito T; Ito T; Omori Y; Tanimoto T
Diabetologia; 1994 Mar; 37(3):328-30. PubMed ID: 8174849
[TBL] [Abstract][Full Text] [Related]
2. The level of erythrocyte aldose reductase is associated with the severity of diabetic retinopathy.
Nishimura C; Hotta Y; Gui T; Seko A; Fujimaki T; Ishikawa T; Hayakawa M; Kanai A; Saito T
Diabetes Res Clin Pract; 1997 Sep; 37(3):173-7. PubMed ID: 9306038
[TBL] [Abstract][Full Text] [Related]
3. Correlation between erythrocyte aldose reductase level and human diabetic retinopathy.
Oishi N; Kubo E; Takamura Y; Maekawa K; Tanimoto T; Akagi Y
Br J Ophthalmol; 2002 Dec; 86(12):1363-6. PubMed ID: 12446366
[TBL] [Abstract][Full Text] [Related]
4. The level of erythrocyte aldose reductase: a risk factor for diabetic neuropathy?
Ito T; Nishimura C; Takahashi Y; Saito T; Omori Y
Diabetes Res Clin Pract; 1997 Jun; 36(3):161-7. PubMed ID: 9237782
[TBL] [Abstract][Full Text] [Related]
5. Aldose reductase and diabetic retinopathy.
Singh R; Dash D; Ansari FJ; Maurya OP; Singh VP
Ann Ophthalmol; 1992 Nov; 24(11):420-2. PubMed ID: 1476398
[TBL] [Abstract][Full Text] [Related]
6. Erythrocyte aldose reductase protein: a clue to elucidate risk factors for diabetic neuropathies independent of glycemic control.
Takahashi Y; Tachikawa T; Ito T; Takayama S; Omori Y; Iwamoto Y
Diabetes Res Clin Pract; 1998 Nov; 42(2):101-7. PubMed ID: 9886746
[TBL] [Abstract][Full Text] [Related]
7. Association of erythrocyte aldose reductase activity with diabetic complications in type 1 diabetes mellitus.
Hamada Y; Kitoh R; Raskin P
Diabet Med; 1993; 10(1):33-8. PubMed ID: 8435985
[TBL] [Abstract][Full Text] [Related]
8. Influence of interindividual variability of aldose reductase protein content on polyol-pathway metabolites and redox state in erythrocytes in diabetic patients.
Hamada Y; Nishimura C; Koh N; Sakakibara F; Nakamura J; Tanimoto T; Hotta N
Diabetes Care; 1998 Jun; 21(6):1014-8. PubMed ID: 9614624
[TBL] [Abstract][Full Text] [Related]
9. No correlation between glycemic control and an increase in erythrocyte aldose reductase activity in type I and type II diabetic patients.
Hamada Y; Hammon K; Raskin P
J Diabetes Complications; 1992; 6(2):111-5. PubMed ID: 1611134
[TBL] [Abstract][Full Text] [Related]
10. Activities of aldose reductase, ATPases, and nucleotide concentrations of erythrocytes in patients with type 2 (non-insulin-dependent) diabetes mellitus.
Song HP; Han XY; He Y; Kang TB; Wu HW
Chin Med J (Engl); 1991 Oct; 104(10):818-24. PubMed ID: 1661222
[TBL] [Abstract][Full Text] [Related]
11. Z-4 allele upstream of the aldose reductase gene is associated with proliferative retinopathy in Japanese patients with NIDDM, and elevated luciferase gene transcription in vitro.
Ikegishi Y; Tawata M; Aida K; Onaya T
Life Sci; 1999; 65(20):2061-70. PubMed ID: 10579460
[TBL] [Abstract][Full Text] [Related]
12. Erythrocyte aldose reductase activity and sorbitol levels in diabetic retinopathy.
Reddy GB; Satyanarayana A; Balakrishna N; Ayyagari R; Padma M; Viswanath K; Petrash JM
Mol Vis; 2008 Mar; 14():593-601. PubMed ID: 18385795
[TBL] [Abstract][Full Text] [Related]
13. Crucial role of aldose reductase activity and plasma glucose level in sorbitol accumulation in erythrocytes from diabetic patients.
Hamada Y; Kitoh R; Raskin P
Diabetes; 1991 Oct; 40(10):1233-40. PubMed ID: 1936586
[TBL] [Abstract][Full Text] [Related]
14. Increased erythrocyte aldose reductase activity in type 1 diabetic patients.
Hamada Y; Kito R; Raskin P
Diabet Med; 1991 Apr; 8(3):226-31. PubMed ID: 1828737
[TBL] [Abstract][Full Text] [Related]
15. Enzyme immunoassay for erythrocyte aldose reductase.
Nishimura C; Hamada Y; Tachikawa T; Ishikawa T; Gui T; Tsubouchi J; Hotta N; Tanimoto T; Urakami T
Clin Chem; 1994 Jun; 40(6):889-94. PubMed ID: 8087983
[TBL] [Abstract][Full Text] [Related]
16. Increased levels of aldose reductase in peripheral mononuclear cells from type 2 diabetic patients with microangiopathy.
Hasegawa G; Obayashi H; Kitamura A; Hashimoto M; Shigeta H; Nakamura N; Kondo M; Nishimura CY
Diabetes Res Clin Pract; 1999 Aug; 45(1):9-14. PubMed ID: 10499880
[TBL] [Abstract][Full Text] [Related]
17. Hyperglycemia-induced activation of human erythrocyte aldose reductase and alterations in kinetic properties.
Srivastava SK; Ansari NH; Hair GA; Jaspan J; Rao MB; Das B
Biochim Biophys Acta; 1986 Mar; 870(2):302-11. PubMed ID: 3082363
[TBL] [Abstract][Full Text] [Related]
18. Quantitative determination of human aldose reductase by enzyme-linked immunosorbent assay. Immunoassay of human aldose reductase.
Nishimura C; Furue M; Ito T; Omori Y; Tanimoto T
Biochem Pharmacol; 1993 Jul; 46(1):21-8. PubMed ID: 8347133
[TBL] [Abstract][Full Text] [Related]
19. Epithelial cell density in cataractous lenses of patients with diabetes: association with erythrocyte aldose reductase.
Kumamoto Y; Takamura Y; Kubo E; Tsuzuki S; Akagi Y
Exp Eye Res; 2007 Sep; 85(3):393-9. PubMed ID: 17655844
[TBL] [Abstract][Full Text] [Related]
20. Correlation between erythrocyte aldose reductase activity and the width of skeletal-muscle capillary basement membrane in insulin-dependent diabetes mellitus.
Hamada Y; Hammon K; Raskin P
J Diabetes Complications; 1992; 6(4):242-6. PubMed ID: 1482782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
